Tekscend Photomask Corp.
429A・Prime Market・Other Products
Tekscend Photomask Corp.
429A・Prime Market・Other Products
Business
Tekscend Photomask Corp. is a company specializing in the manufacture and sale of photomasks, which are indispensable to the semiconductor manufacturing process. It succeeded to the Photomask Business of the TOPPAN Group in April 2022, and listed on the Prime Market of the Tokyo Stock Exchange in October 2025. The company operates a total of eight plants across five sites in Asia, one in the United States, and two in Europe, with foundries, IDMs, research institutions, and other entities as its main customers. It offers a wide lineup of products, from leading-edge products including EUV Photomasks to legacy-node products, all on a complete build-to-order basis, and maintained the top position with a 37.8% share of the merchant photomask market in 2024 (SEMI survey). In addition to the Photomask Business, the company is also working to develop new business areas, such as Nanoimprint Molds, by applying its fine processing technology.
Business Model
The company adopts a fully build-to-order model in which photomasks are manufactured and delivered based on semiconductor circuit pattern data supplied by customers, through processes including electron beam writing, development, etching, and inspection. Orders arise continuously from the R&D and prototyping phase through to the mass-production phase, and adoption at the R&D stage creates a technical barrier to entry at the mass-production stage. By virtually consolidating its eight global plants into a single "virtual" plant, the company maximizes utilization rates and achieves a high operating margin (21.2% in FY2026 (ending March 2026)).
Company Strengths
According to SEMI's "2024 PHOTOMASK CHARACTERIZATION STUDY," the Group's share of the merchant photomask market stood at 37.8%, ranking first. In addition to over 50 years of technological accumulation since the start of mass production in 1968, the Group has built a global 8-plant network through acquisitions such as DuPont Photomasks. Adoption at the R&D stage becomes a technical barrier to entry at the mass production stage, achieving customer lock-in.
The Group began R&D on EUV masks ahead of the industry in the early 2000s and has now established a mass production system. Multi-beam writers have already been installed at the Asaka and Dresden plants. In January 2024, the Group signed a five-year joint R&D agreement with IBM for EUV masks for 2nm logic. The Group is also advancing collaboration with imec and the development of blanks for High-NA, building a first-mover advantage in next-generation technology.
The 8 plants across Asia, North America, and Europe work in coordination, leveling capacity through inter-site production outsourcing. An AI-driven production management system improves delivery date prediction accuracy and optimizes equipment utilization. Data-matching technology across sites and equipment enables customer qualification to be obtained at multiple plants in a short period. Total capital expenditure for FY2026 (ending March 2026) reached ¥33,236 million, aimed at continuously strengthening production capacity.
ENVALITH's Perspective
Performance Trend
In FY2026 (ending March 2026), revenue reached ¥129,576 million (up 9.8% year on year), achieving revenue growth for the second consecutive period. As an external factor, demand for both leading-edge and mature photomasks remained solid, supported by the continued high level of investment in data centers for generative AI and cloud services. On the other hand, operating profit declined slightly to ¥27,530 million (down 2.4% year on year) due to increased material costs and depreciation expenses, along with one-time listing-related expenses. Profit for the period rose sharply to ¥24,947 million (up 150.9% year on year), as corporate income tax expense decreased significantly from ¥20,825 million in the previous period to ¥8,484 million. For FY2027 (ending March 2027), the company forecasts revenue of ¥140,100 million (up 8.1% year on year) and operating profit of ¥29,800 million (up 8.2% year on year), with a recovery in operating profit expected once one-time expenses are no longer incurred.
Growth Strategy
Three-pronged growth strategy: deepening advanced EUV technology, expanding global production capacity, and capturing external sales demand
The company is constructing a new plant in Singapore, targeting the start of production from 2027 onward. It aims to secure capacity to meet growing demand for advanced photomasks used in AI and data centers, and to strengthen its supply framework in the Asian region. Part of the ¥33,207 million in capital expenditure for property, plant and equipment in FY2026 (ending March 2026) has been allocated to this initiative.
The company is introducing new lines at its existing facilities in the US and South Korea to enhance production capacity for advanced nodes. Against the backdrop of economic security considerations and the trend toward reshoring semiconductor supply chains, it is building a framework to respond to customer demand in each region. Production is expected to start from 2027 onward, contributing to business expansion.
The company is advancing efforts to establish mass-production lines for EUV masks at its Japan facility. As demand for high-precision EUV masks grows amid ongoing miniaturization and higher integration of semiconductors, establishing a mass-production framework will help maintain and strengthen competitive advantage in the advanced technology domain. EUV masks are high-value-added products and are also expected to contribute to improved profitability.
As AI-driven demand grows, memory manufacturers focusing on development for cutting-edge memory are expected to increasingly outsource photomask procurement. By capturing new outsourcing demand from memory manufacturers that have traditionally relied on in-house production, the company aims to achieve sales growth that outpaces the growth of the external photomask market.
Last updated: July 19, 2026